Reimbursement status of medicinal products aginst hypertension
On 6 March 2006 , the Danish Medicines Agency wrote a letter to a number of scientific societies to make them clarify certain aspects of the treatment of hypertension in Denmark . So far, four scientific societies have replied. When we have received all the replies, they will be published on this website and the Reimbursement Committee will continue the discussion on the reimbursement status of medicinal products for hypertension. In the fact box to the right you can find the letter to the scientific societies (in Danish only).
For further information, please contact the Reimbursement Department, email@example.com.
The Danish Medicines Agency, 4 July 2006